PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr2f1
|
ENSMUSG00000069171.15 | Nr2f1 |
Nr4a1
|
ENSMUSG00000023034.8 | Nr4a1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nr4a1 | mm39_v1_chr15_+_101164719_101164740 | -0.44 | 1.1e-04 | Click! |
Nr2f1 | mm39_v1_chr13_-_78347876_78347982 | -0.24 | 4.3e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_46146558 | 67.45 |
ENSMUST00000121916.8
ENSMUST00000034586.9 |
Apoc3
|
apolipoprotein C-III |
chr9_-_46146928 | 47.19 |
ENSMUST00000118649.8
|
Apoc3
|
apolipoprotein C-III |
chr4_+_115375461 | 39.02 |
ENSMUST00000058785.10
ENSMUST00000094886.4 |
Cyp4a10
|
cytochrome P450, family 4, subfamily a, polypeptide 10 |
chr7_-_140856642 | 35.13 |
ENSMUST00000080654.7
ENSMUST00000167263.9 |
Cdhr5
|
cadherin-related family member 5 |
chr7_-_105249308 | 30.33 |
ENSMUST00000210531.2
ENSMUST00000033185.10 |
Hpx
|
hemopexin |
chr14_+_75479727 | 29.93 |
ENSMUST00000022576.10
|
Cpb2
|
carboxypeptidase B2 (plasma) |
chr3_-_137837117 | 27.28 |
ENSMUST00000029805.13
|
Mttp
|
microsomal triglyceride transfer protein |
chr11_-_53313950 | 26.53 |
ENSMUST00000036045.6
|
Leap2
|
liver-expressed antimicrobial peptide 2 |
chr7_+_140500808 | 25.68 |
ENSMUST00000106045.8
ENSMUST00000183845.8 |
Nlrp6
|
NLR family, pyrin domain containing 6 |
chr2_+_172994841 | 25.23 |
ENSMUST00000029017.6
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr10_+_128030315 | 24.02 |
ENSMUST00000044776.13
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr5_-_123320767 | 22.81 |
ENSMUST00000154713.8
ENSMUST00000031398.14 |
Hpd
|
4-hydroxyphenylpyruvic acid dioxygenase |
chr14_-_30637344 | 22.23 |
ENSMUST00000226547.2
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr16_+_17149235 | 21.90 |
ENSMUST00000023450.15
ENSMUST00000231884.2 |
Serpind1
|
serine (or cysteine) peptidase inhibitor, clade D, member 1 |
chr15_-_96947963 | 21.48 |
ENSMUST00000230907.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr7_+_140500848 | 21.22 |
ENSMUST00000184560.2
|
Nlrp6
|
NLR family, pyrin domain containing 6 |
chr9_-_107546166 | 20.31 |
ENSMUST00000177567.8
|
Slc38a3
|
solute carrier family 38, member 3 |
chr6_+_90527762 | 18.82 |
ENSMUST00000130418.8
ENSMUST00000032175.11 ENSMUST00000203111.2 |
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1 |
chr9_-_107546195 | 18.73 |
ENSMUST00000192990.6
|
Slc38a3
|
solute carrier family 38, member 3 |
chr2_+_126398048 | 18.63 |
ENSMUST00000141482.3
|
Slc27a2
|
solute carrier family 27 (fatty acid transporter), member 2 |
chr16_-_20549294 | 18.20 |
ENSMUST00000231826.2
ENSMUST00000076422.13 ENSMUST00000232217.2 |
Thpo
|
thrombopoietin |
chr10_+_59239466 | 18.03 |
ENSMUST00000009790.14
|
Pla2g12b
|
phospholipase A2, group XIIB |
chr9_-_70841881 | 17.33 |
ENSMUST00000214995.2
|
Lipc
|
lipase, hepatic |
chr18_-_35760260 | 17.21 |
ENSMUST00000025212.8
|
Slc23a1
|
solute carrier family 23 (nucleobase transporters), member 1 |
chr11_+_75400889 | 16.72 |
ENSMUST00000042972.7
|
Rilp
|
Rab interacting lysosomal protein |
chr17_-_56424265 | 16.09 |
ENSMUST00000113072.3
|
Plin5
|
perilipin 5 |
chr4_+_99812912 | 15.96 |
ENSMUST00000102783.5
|
Pgm1
|
phosphoglucomutase 1 |
chr17_-_56424577 | 15.70 |
ENSMUST00000019808.12
|
Plin5
|
perilipin 5 |
chr11_-_116089595 | 15.41 |
ENSMUST00000072948.11
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr11_-_46581135 | 15.26 |
ENSMUST00000169584.8
|
Timd2
|
T cell immunoglobulin and mucin domain containing 2 |
chr10_+_128030500 | 15.01 |
ENSMUST00000123291.2
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr4_+_140688514 | 14.95 |
ENSMUST00000010007.9
|
Sdhb
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
chr19_+_43770619 | 14.46 |
ENSMUST00000026208.6
|
Abcc2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
chr19_-_43512929 | 14.41 |
ENSMUST00000026196.14
|
Got1
|
glutamic-oxaloacetic transaminase 1, soluble |
chr2_+_71811526 | 13.99 |
ENSMUST00000090826.12
ENSMUST00000102698.10 |
Rapgef4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr9_-_70842090 | 13.91 |
ENSMUST00000034731.10
|
Lipc
|
lipase, hepatic |
chr4_+_99786611 | 13.67 |
ENSMUST00000058351.16
|
Pgm1
|
phosphoglucomutase 1 |
chr1_-_120001752 | 13.66 |
ENSMUST00000056089.8
|
Tmem37
|
transmembrane protein 37 |
chr5_-_87288177 | 13.34 |
ENSMUST00000067790.7
|
Ugt2b5
|
UDP glucuronosyltransferase 2 family, polypeptide B5 |
chr1_+_139429430 | 13.18 |
ENSMUST00000027615.7
|
F13b
|
coagulation factor XIII, beta subunit |
chr13_-_74498320 | 13.10 |
ENSMUST00000221594.2
ENSMUST00000022062.8 |
Sdha
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp) |
chr3_-_81883509 | 13.01 |
ENSMUST00000029645.14
ENSMUST00000193879.2 |
Tdo2
|
tryptophan 2,3-dioxygenase |
chr2_-_91466739 | 12.66 |
ENSMUST00000111335.2
ENSMUST00000028681.15 |
F2
|
coagulation factor II |
chr3_+_82915031 | 12.63 |
ENSMUST00000048486.13
ENSMUST00000194175.2 |
Fgg
|
fibrinogen gamma chain |
chr1_+_88093726 | 12.36 |
ENSMUST00000097659.5
|
Ugt1a5
|
UDP glucuronosyltransferase 1 family, polypeptide A5 |
chr4_-_60457902 | 12.12 |
ENSMUST00000084548.11
ENSMUST00000103012.10 ENSMUST00000107499.4 |
Mup1
|
major urinary protein 1 |
chr11_-_75330302 | 11.80 |
ENSMUST00000043696.9
|
Serpinf2
|
serine (or cysteine) peptidase inhibitor, clade F, member 2 |
chr11_-_75330415 | 11.68 |
ENSMUST00000128330.8
|
Serpinf2
|
serine (or cysteine) peptidase inhibitor, clade F, member 2 |
chr11_+_74540284 | 11.65 |
ENSMUST00000117818.2
ENSMUST00000092915.12 |
Cluh
|
clustered mitochondria (cluA/CLU1) homolog |
chr1_-_139786421 | 11.48 |
ENSMUST00000194186.6
ENSMUST00000094489.5 ENSMUST00000239380.2 |
Cfhr2
|
complement factor H-related 2 |
chrX_+_149372903 | 11.43 |
ENSMUST00000080884.11
|
Pfkfb1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
chr4_+_141473983 | 11.36 |
ENSMUST00000038161.5
|
Agmat
|
agmatine ureohydrolase (agmatinase) |
chr7_-_30754193 | 11.29 |
ENSMUST00000205778.2
|
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr17_+_85335775 | 11.23 |
ENSMUST00000024944.9
|
Slc3a1
|
solute carrier family 3, member 1 |
chr15_+_76227695 | 11.21 |
ENSMUST00000023210.8
ENSMUST00000231045.2 |
Cyc1
|
cytochrome c-1 |
chr8_+_95564949 | 11.04 |
ENSMUST00000034234.15
ENSMUST00000159871.4 |
Coq9
|
coenzyme Q9 |
chr4_-_141351110 | 11.00 |
ENSMUST00000038661.8
|
Slc25a34
|
solute carrier family 25, member 34 |
chr4_-_62005498 | 10.94 |
ENSMUST00000107488.4
ENSMUST00000107472.8 ENSMUST00000084531.11 |
Mup3
|
major urinary protein 3 |
chr9_-_65330231 | 10.94 |
ENSMUST00000065894.7
|
Slc51b
|
solute carrier family 51, beta subunit |
chr4_-_6275629 | 10.91 |
ENSMUST00000029905.2
|
Cyp7a1
|
cytochrome P450, family 7, subfamily a, polypeptide 1 |
chr14_+_79086665 | 10.80 |
ENSMUST00000227255.2
|
Vwa8
|
von Willebrand factor A domain containing 8 |
chr19_-_43974990 | 10.48 |
ENSMUST00000026210.5
|
Cpn1
|
carboxypeptidase N, polypeptide 1 |
chr7_-_19415301 | 10.41 |
ENSMUST00000150569.9
ENSMUST00000127648.4 ENSMUST00000003071.10 |
Gm44805
Apoc4
|
predicted gene 44805 apolipoprotein C-IV |
chr7_-_30754223 | 10.37 |
ENSMUST00000206012.2
ENSMUST00000108110.5 |
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr11_-_11848107 | 10.32 |
ENSMUST00000178704.8
|
Ddc
|
dopa decarboxylase |
chr11_-_53321606 | 10.30 |
ENSMUST00000061326.5
ENSMUST00000109021.4 |
Uqcrq
|
ubiquinol-cytochrome c reductase, complex III subunit VII |
chr5_-_108822619 | 10.16 |
ENSMUST00000119270.2
ENSMUST00000163328.8 ENSMUST00000136227.2 |
Slc26a1
|
solute carrier family 26 (sulfate transporter), member 1 |
chr9_-_44714263 | 10.12 |
ENSMUST00000044694.8
|
Ttc36
|
tetratricopeptide repeat domain 36 |
chr9_-_110818679 | 10.05 |
ENSMUST00000084922.6
ENSMUST00000199891.2 |
Rtp3
|
receptor transporter protein 3 |
chr4_-_60697274 | 10.03 |
ENSMUST00000117932.2
|
Mup12
|
major urinary protein 12 |
chr3_+_130411097 | 9.96 |
ENSMUST00000166187.8
ENSMUST00000072271.13 |
Etnppl
|
ethanolamine phosphate phospholyase |
chr1_+_67162176 | 9.90 |
ENSMUST00000027144.8
|
Cps1
|
carbamoyl-phosphate synthetase 1 |
chr4_-_60777462 | 9.86 |
ENSMUST00000211875.2
|
Mup22
|
major urinary protein 22 |
chr7_+_51537645 | 9.83 |
ENSMUST00000208711.2
|
Gas2
|
growth arrest specific 2 |
chr2_-_69172944 | 9.82 |
ENSMUST00000102709.8
ENSMUST00000102710.10 ENSMUST00000180142.2 |
Abcb11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
chr7_+_44114815 | 9.80 |
ENSMUST00000035929.11
ENSMUST00000146128.8 |
Aspdh
|
aspartate dehydrogenase domain containing |
chr4_-_107164347 | 9.78 |
ENSMUST00000082426.11
|
Dio1
|
deiodinase, iodothyronine, type I |
chr4_-_107164315 | 9.78 |
ENSMUST00000126291.2
ENSMUST00000106748.2 ENSMUST00000129138.2 |
Dio1
|
deiodinase, iodothyronine, type I |
chr4_+_134123631 | 9.75 |
ENSMUST00000105869.9
|
Pafah2
|
platelet-activating factor acetylhydrolase 2 |
chr9_+_107957621 | 9.69 |
ENSMUST00000035211.14
|
Mst1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr16_-_22847808 | 9.67 |
ENSMUST00000115349.9
|
Kng2
|
kininogen 2 |
chr9_+_107957640 | 9.64 |
ENSMUST00000162886.2
|
Mst1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr11_-_116089866 | 9.64 |
ENSMUST00000066587.12
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr2_+_58645189 | 9.63 |
ENSMUST00000102755.4
ENSMUST00000230627.2 ENSMUST00000229923.2 |
Upp2
|
uridine phosphorylase 2 |
chr13_-_41981812 | 9.53 |
ENSMUST00000223337.2
ENSMUST00000221691.2 |
Adtrp
|
androgen dependent TFPI regulating protein |
chr16_-_22847760 | 9.52 |
ENSMUST00000039338.13
|
Kng2
|
kininogen 2 |
chr18_+_77861656 | 9.46 |
ENSMUST00000114748.2
|
Atp5a1
|
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1 |
chr1_-_139487951 | 9.31 |
ENSMUST00000023965.8
|
Cfhr1
|
complement factor H-related 1 |
chr4_-_60222580 | 9.26 |
ENSMUST00000095058.5
ENSMUST00000163931.8 |
Mup8
|
major urinary protein 8 |
chr16_-_23339329 | 9.22 |
ENSMUST00000230040.2
ENSMUST00000229619.2 |
Masp1
|
mannan-binding lectin serine peptidase 1 |
chr16_-_22847829 | 9.20 |
ENSMUST00000100046.9
|
Kng2
|
kininogen 2 |
chr17_-_26087696 | 9.18 |
ENSMUST00000236479.2
ENSMUST00000235806.2 ENSMUST00000026828.7 |
Mcrip2
|
MAPK regulated corepressor interacting protein 2 |
chr1_-_139708906 | 9.16 |
ENSMUST00000111986.8
ENSMUST00000027612.11 ENSMUST00000111989.9 |
Cfhr4
|
complement factor H-related 4 |
chr11_-_11848044 | 9.13 |
ENSMUST00000066237.10
|
Ddc
|
dopa decarboxylase |
chr8_+_70525546 | 9.05 |
ENSMUST00000110160.9
ENSMUST00000049197.6 |
Tm6sf2
|
transmembrane 6 superfamily member 2 |
chr16_+_31241085 | 9.02 |
ENSMUST00000089759.9
|
Bdh1
|
3-hydroxybutyrate dehydrogenase, type 1 |
chr1_+_133237516 | 8.82 |
ENSMUST00000094557.7
ENSMUST00000192465.2 ENSMUST00000193888.6 ENSMUST00000194044.6 ENSMUST00000184603.8 |
Golt1a
Gm28040
Gm28040
|
golgi transport 1A predicted gene, 28040 predicted gene, 28040 |
chr12_+_31488208 | 8.79 |
ENSMUST00000001254.6
|
Slc26a3
|
solute carrier family 26, member 3 |
chr1_+_131725119 | 8.79 |
ENSMUST00000112393.9
ENSMUST00000048660.12 |
Pm20d1
|
peptidase M20 domain containing 1 |
chr7_-_79492091 | 8.76 |
ENSMUST00000049004.8
|
Anpep
|
alanyl (membrane) aminopeptidase |
chr6_-_142418801 | 8.61 |
ENSMUST00000032371.8
|
Gys2
|
glycogen synthase 2 |
chr8_-_124621483 | 8.59 |
ENSMUST00000034453.6
ENSMUST00000212584.2 |
Acta1
|
actin, alpha 1, skeletal muscle |
chr7_-_30754240 | 8.50 |
ENSMUST00000206860.2
ENSMUST00000071697.11 |
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr14_+_79086492 | 8.45 |
ENSMUST00000040990.7
|
Vwa8
|
von Willebrand factor A domain containing 8 |
chr9_+_46179899 | 8.30 |
ENSMUST00000121598.8
|
Apoa5
|
apolipoprotein A-V |
chr13_+_74269554 | 8.28 |
ENSMUST00000036208.7
ENSMUST00000225423.2 ENSMUST00000221703.2 |
Slc9a3
|
solute carrier family 9 (sodium/hydrogen exchanger), member 3 |
chrX_-_16683578 | 8.26 |
ENSMUST00000040820.13
|
Maob
|
monoamine oxidase B |
chrX_+_59044796 | 8.21 |
ENSMUST00000033477.5
|
F9
|
coagulation factor IX |
chr5_-_66308421 | 8.11 |
ENSMUST00000200775.4
ENSMUST00000094756.11 |
Rbm47
|
RNA binding motif protein 47 |
chr2_-_25390625 | 8.11 |
ENSMUST00000040042.11
|
C8g
|
complement component 8, gamma polypeptide |
chr10_+_76411474 | 8.01 |
ENSMUST00000001183.8
|
Ftcd
|
formiminotransferase cyclodeaminase |
chr17_-_35081456 | 7.99 |
ENSMUST00000025229.11
ENSMUST00000176203.9 ENSMUST00000128767.8 |
Cfb
|
complement factor B |
chr9_+_46151994 | 7.98 |
ENSMUST00000034585.7
|
Apoa4
|
apolipoprotein A-IV |
chr3_-_79535966 | 7.96 |
ENSMUST00000120992.8
|
Etfdh
|
electron transferring flavoprotein, dehydrogenase |
chr3_+_130411294 | 7.88 |
ENSMUST00000163620.8
|
Etnppl
|
ethanolamine phosphate phospholyase |
chr2_+_58644922 | 7.83 |
ENSMUST00000059102.13
|
Upp2
|
uridine phosphorylase 2 |
chr2_-_136733282 | 7.80 |
ENSMUST00000028730.13
ENSMUST00000110089.9 ENSMUST00000227806.2 |
Mkks
ENSMUSG00000115423.3
|
McKusick-Kaufman syndrome novel protein |
chrX_-_37545311 | 7.76 |
ENSMUST00000074913.12
ENSMUST00000016678.14 ENSMUST00000061755.9 |
Lamp2
|
lysosomal-associated membrane protein 2 |
chrX_-_47602395 | 7.69 |
ENSMUST00000114945.9
ENSMUST00000037349.8 |
Aifm1
|
apoptosis-inducing factor, mitochondrion-associated 1 |
chr4_+_115420817 | 7.58 |
ENSMUST00000141033.8
ENSMUST00000030486.15 |
Cyp4a31
|
cytochrome P450, family 4, subfamily a, polypeptide 31 |
chr4_+_115420876 | 7.57 |
ENSMUST00000126645.8
ENSMUST00000030480.4 |
Cyp4a31
|
cytochrome P450, family 4, subfamily a, polypeptide 31 |
chr1_-_140111138 | 7.52 |
ENSMUST00000111976.9
ENSMUST00000066859.13 |
Cfh
|
complement component factor h |
chr3_+_118355778 | 7.48 |
ENSMUST00000039177.12
|
Dpyd
|
dihydropyrimidine dehydrogenase |
chr6_+_145156860 | 7.47 |
ENSMUST00000111725.8
ENSMUST00000111726.10 ENSMUST00000039729.5 ENSMUST00000111723.8 ENSMUST00000111724.8 ENSMUST00000111721.2 ENSMUST00000111719.2 |
Etfrf1
|
electron transfer flavoprotein regulatory factor 1 |
chr1_-_140111018 | 7.44 |
ENSMUST00000192880.6
ENSMUST00000111977.8 |
Cfh
|
complement component factor h |
chr6_+_138117519 | 7.34 |
ENSMUST00000120939.8
ENSMUST00000204628.3 ENSMUST00000140932.2 ENSMUST00000120302.8 |
Mgst1
|
microsomal glutathione S-transferase 1 |
chr7_+_44114857 | 7.31 |
ENSMUST00000135624.2
|
Aspdh
|
aspartate dehydrogenase domain containing |
chr16_-_22848153 | 7.29 |
ENSMUST00000232459.2
|
Kng2
|
kininogen 2 |
chr8_+_121395047 | 7.23 |
ENSMUST00000181795.2
|
Cox4i1
|
cytochrome c oxidase subunit 4I1 |
chr7_-_30755007 | 7.21 |
ENSMUST00000206474.2
ENSMUST00000205807.2 ENSMUST00000039909.13 ENSMUST00000206305.2 ENSMUST00000205439.2 |
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr3_+_32791139 | 7.15 |
ENSMUST00000127477.8
ENSMUST00000121778.8 ENSMUST00000154257.8 |
Ndufb5
|
NADH:ubiquinone oxidoreductase subunit B5 |
chr1_+_166081664 | 7.13 |
ENSMUST00000111416.7
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr16_-_23339548 | 7.11 |
ENSMUST00000089883.7
|
Masp1
|
mannan-binding lectin serine peptidase 1 |
chrX_+_138511360 | 7.06 |
ENSMUST00000113026.2
|
Rnf128
|
ring finger protein 128 |
chr19_-_10581622 | 6.99 |
ENSMUST00000037678.7
|
Tkfc
|
triokinase, FMN cyclase |
chr5_-_147259245 | 6.96 |
ENSMUST00000100433.5
|
Urad
|
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5) decarboxylase |
chr16_+_3854806 | 6.93 |
ENSMUST00000137748.8
ENSMUST00000006136.11 ENSMUST00000157044.8 ENSMUST00000120009.8 |
Dnase1
|
deoxyribonuclease I |
chr3_-_10400710 | 6.91 |
ENSMUST00000078748.4
|
Slc10a5
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 5 |
chr7_-_45887888 | 6.90 |
ENSMUST00000154292.9
ENSMUST00000078680.13 ENSMUST00000177212.8 ENSMUST00000009667.12 |
Ush1c
|
USH1 protein network component harmonin |
chr6_-_11907392 | 6.77 |
ENSMUST00000204084.3
ENSMUST00000031637.8 ENSMUST00000204978.3 ENSMUST00000204714.2 |
Ndufa4
|
Ndufa4, mitochondrial complex associated |
chr10_-_128237087 | 6.72 |
ENSMUST00000042666.13
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr19_-_4548602 | 6.68 |
ENSMUST00000048482.8
|
2010003K11Rik
|
RIKEN cDNA 2010003K11 gene |
chr4_+_128887017 | 6.59 |
ENSMUST00000030583.13
ENSMUST00000102604.11 |
Ak2
|
adenylate kinase 2 |
chr10_-_42354482 | 6.55 |
ENSMUST00000041024.15
|
Afg1l
|
AFG1 like ATPase |
chr17_-_35081129 | 6.40 |
ENSMUST00000154526.8
|
Cfb
|
complement factor B |
chr17_-_84154196 | 6.35 |
ENSMUST00000234214.2
|
Haao
|
3-hydroxyanthranilate 3,4-dioxygenase |
chr7_+_45546365 | 6.31 |
ENSMUST00000069772.16
ENSMUST00000210503.2 ENSMUST00000209350.2 |
Tmem143
|
transmembrane protein 143 |
chr11_+_115353290 | 6.30 |
ENSMUST00000106532.4
ENSMUST00000092445.12 ENSMUST00000153466.2 |
Slc16a5
|
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
chr15_+_85619765 | 6.18 |
ENSMUST00000109423.8
|
Ppara
|
peroxisome proliferator activated receptor alpha |
chr11_+_69945157 | 6.17 |
ENSMUST00000108585.9
ENSMUST00000018699.13 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr16_-_56984137 | 6.15 |
ENSMUST00000231733.2
|
Nit2
|
nitrilase family, member 2 |
chr3_+_96737385 | 6.13 |
ENSMUST00000058865.14
|
Pdzk1
|
PDZ domain containing 1 |
chr5_-_115109118 | 6.10 |
ENSMUST00000031535.12
|
Hnf1a
|
HNF1 homeobox A |
chr10_+_127919142 | 6.07 |
ENSMUST00000026459.6
|
Atp5b
|
ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit |
chr10_-_90959853 | 6.04 |
ENSMUST00000170810.8
ENSMUST00000076694.13 |
Slc25a3
|
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3 |
chr4_-_129121676 | 6.04 |
ENSMUST00000106051.8
|
C77080
|
expressed sequence C77080 |
chr5_+_114284585 | 5.99 |
ENSMUST00000102582.8
|
Acacb
|
acetyl-Coenzyme A carboxylase beta |
chr2_-_73741664 | 5.93 |
ENSMUST00000111996.8
ENSMUST00000018914.3 |
Atp5g3
|
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C3 (subunit 9) |
chr15_-_102097466 | 5.87 |
ENSMUST00000023805.3
|
Csad
|
cysteine sulfinic acid decarboxylase |
chr15_+_7159038 | 5.87 |
ENSMUST00000067190.12
ENSMUST00000164529.9 |
Lifr
|
LIF receptor alpha |
chr3_+_32583681 | 5.86 |
ENSMUST00000147350.8
|
Mfn1
|
mitofusin 1 |
chr4_+_117109204 | 5.84 |
ENSMUST00000125943.8
ENSMUST00000106434.8 |
Tmem53
|
transmembrane protein 53 |
chr14_+_55813074 | 5.82 |
ENSMUST00000022826.7
|
Fitm1
|
fat storage-inducing transmembrane protein 1 |
chr7_+_30193047 | 5.81 |
ENSMUST00000058280.13
ENSMUST00000133318.8 ENSMUST00000142575.8 ENSMUST00000131040.2 |
Prodh2
|
proline dehydrogenase (oxidase) 2 |
chr4_-_115932219 | 5.79 |
ENSMUST00000050580.11
ENSMUST00000078676.6 |
Uqcrh
|
ubiquinol-cytochrome c reductase hinge protein |
chr5_-_30360113 | 5.77 |
ENSMUST00000156859.3
|
Hadha
|
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
chr3_+_96736774 | 5.76 |
ENSMUST00000138014.8
|
Pdzk1
|
PDZ domain containing 1 |
chr4_+_117109148 | 5.67 |
ENSMUST00000062824.12
|
Tmem53
|
transmembrane protein 53 |
chr19_+_44980565 | 5.61 |
ENSMUST00000179305.2
|
Sema4g
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G |
chr14_-_55995912 | 5.60 |
ENSMUST00000001497.9
|
Cideb
|
cell death-inducing DNA fragmentation factor, alpha subunit-like effector B |
chr9_-_21996693 | 5.52 |
ENSMUST00000179422.8
ENSMUST00000098937.10 ENSMUST00000177967.2 ENSMUST00000180180.8 |
Ecsit
|
ECSIT signalling integrator |
chr12_+_41074328 | 5.45 |
ENSMUST00000134965.8
|
Immp2l
|
IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae) |
chr1_-_120047868 | 5.41 |
ENSMUST00000112648.8
|
Dbi
|
diazepam binding inhibitor |
chr3_+_118355811 | 5.40 |
ENSMUST00000149101.3
|
Dpyd
|
dihydropyrimidine dehydrogenase |
chr10_+_110756031 | 5.35 |
ENSMUST00000220409.2
ENSMUST00000219502.2 |
Csrp2
|
cysteine and glycine-rich protein 2 |
chr1_-_175453117 | 5.35 |
ENSMUST00000027810.14
|
Fh1
|
fumarate hydratase 1 |
chr4_+_133280680 | 5.29 |
ENSMUST00000042706.3
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr1_-_192946359 | 5.26 |
ENSMUST00000161737.8
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1 |
chr2_-_104573179 | 5.25 |
ENSMUST00000028595.8
|
Depdc7
|
DEP domain containing 7 |
chr5_-_115257336 | 5.21 |
ENSMUST00000031524.11
|
Acads
|
acyl-Coenzyme A dehydrogenase, short chain |
chr15_-_102097387 | 5.16 |
ENSMUST00000230288.2
|
Csad
|
cysteine sulfinic acid decarboxylase |
chr5_+_89175815 | 5.15 |
ENSMUST00000130041.8
|
Slc4a4
|
solute carrier family 4 (anion exchanger), member 4 |
chr6_+_42222841 | 5.13 |
ENSMUST00000031897.8
|
Gstk1
|
glutathione S-transferase kappa 1 |
chr3_+_32583602 | 5.13 |
ENSMUST00000091257.11
|
Mfn1
|
mitofusin 1 |
chr1_+_4878046 | 5.09 |
ENSMUST00000027036.11
ENSMUST00000150971.8 ENSMUST00000119612.9 ENSMUST00000137887.8 ENSMUST00000115529.8 |
Lypla1
|
lysophospholipase 1 |
chr7_+_114367971 | 5.06 |
ENSMUST00000117543.3
ENSMUST00000151464.2 |
Insc
|
INSC spindle orientation adaptor protein |
chr10_-_42354276 | 5.06 |
ENSMUST00000151747.8
|
Afg1l
|
AFG1 like ATPase |
chr8_+_120121612 | 5.04 |
ENSMUST00000098367.5
|
Mlycd
|
malonyl-CoA decarboxylase |
chr16_-_91728162 | 5.02 |
ENSMUST00000139277.8
ENSMUST00000154661.8 |
Atp5o
|
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
chr7_-_48494959 | 5.02 |
ENSMUST00000208050.2
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr5_-_66309244 | 5.01 |
ENSMUST00000167950.8
|
Rbm47
|
RNA binding motif protein 47 |
chr3_+_96736600 | 5.00 |
ENSMUST00000135031.8
|
Pdzk1
|
PDZ domain containing 1 |
chr3_+_122688721 | 5.00 |
ENSMUST00000023820.6
|
Fabp2
|
fatty acid binding protein 2, intestinal |
chr13_-_86194889 | 4.98 |
ENSMUST00000131011.2
|
Cox7c
|
cytochrome c oxidase subunit 7C |
chr2_-_134396268 | 4.90 |
ENSMUST00000028704.3
|
Hao1
|
hydroxyacid oxidase 1, liver |
chr1_-_164285914 | 4.88 |
ENSMUST00000027863.13
|
Atp1b1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr7_+_127399789 | 4.86 |
ENSMUST00000125188.8
|
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr18_+_45402018 | 4.85 |
ENSMUST00000183850.8
ENSMUST00000066890.14 |
Kcnn2
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
chr19_-_47079052 | 4.83 |
ENSMUST00000235771.2
ENSMUST00000096014.5 ENSMUST00000236170.2 |
Atp5md
|
ATP synthase membrane subunit DAPIT |
chr9_+_107217786 | 4.80 |
ENSMUST00000042581.4
|
6430571L13Rik
|
RIKEN cDNA 6430571L13 gene |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
28.7 | 114.6 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
16.1 | 64.3 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
10.0 | 29.9 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
8.4 | 42.0 | GO:1904970 | brush border assembly(GO:1904970) |
6.6 | 19.8 | GO:0006106 | fumarate metabolic process(GO:0006106) |
6.4 | 31.8 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
6.3 | 18.8 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
6.2 | 31.2 | GO:0034371 | chylomicron remodeling(GO:0034371) |
6.2 | 18.6 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
5.7 | 17.2 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
5.7 | 34.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
5.6 | 16.7 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
4.9 | 4.9 | GO:0009441 | glycolate metabolic process(GO:0009441) |
4.5 | 18.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
4.3 | 13.0 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
4.3 | 30.3 | GO:0060332 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) heme transport(GO:0015886) positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
4.3 | 12.9 | GO:0019860 | uracil catabolic process(GO:0006212) uracil metabolic process(GO:0019860) |
4.2 | 25.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
4.1 | 24.8 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
4.1 | 45.4 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
3.7 | 11.0 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
3.6 | 14.5 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
3.5 | 10.5 | GO:0030070 | insulin processing(GO:0030070) |
3.4 | 23.5 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
3.3 | 16.6 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
3.1 | 15.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.1 | 12.2 | GO:0015811 | L-cystine transport(GO:0015811) |
3.0 | 15.2 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
3.0 | 24.3 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
3.0 | 27.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
2.9 | 8.8 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
2.9 | 17.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
2.8 | 14.0 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
2.8 | 19.5 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
2.7 | 16.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
2.6 | 12.9 | GO:0051715 | cytolysis in other organism(GO:0051715) |
2.6 | 7.8 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
2.5 | 22.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
2.5 | 55.3 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
2.2 | 11.0 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
2.2 | 6.6 | GO:1904766 | negative regulation of macroautophagy by TORC1 signaling(GO:1904766) |
2.2 | 11.0 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
2.2 | 10.9 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
2.1 | 19.3 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
2.1 | 8.3 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.1 | 8.3 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
2.0 | 29.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
2.0 | 7.8 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
1.9 | 5.8 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
1.9 | 7.7 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
1.9 | 11.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
1.9 | 18.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.8 | 5.4 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
1.8 | 14.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.8 | 5.3 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
1.7 | 5.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.7 | 5.0 | GO:1903920 | positive regulation of actin filament severing(GO:1903920) |
1.7 | 20.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.7 | 8.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
1.6 | 8.0 | GO:0006548 | histidine catabolic process(GO:0006548) |
1.6 | 11.2 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
1.5 | 16.9 | GO:0015879 | carnitine transport(GO:0015879) |
1.5 | 19.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
1.5 | 22.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.5 | 3.0 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
1.4 | 9.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) drug export(GO:0046618) |
1.4 | 2.7 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
1.3 | 2.7 | GO:0009644 | response to high light intensity(GO:0009644) |
1.3 | 4.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.3 | 3.9 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
1.2 | 6.2 | GO:0072363 | regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072363) |
1.2 | 6.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.2 | 4.8 | GO:0061235 | regulation of pronephros size(GO:0035565) mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
1.2 | 19.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.2 | 7.0 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.2 | 3.5 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
1.2 | 15.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.1 | 11.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.1 | 14.8 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.1 | 10.2 | GO:0019532 | oxalate transport(GO:0019532) |
1.1 | 5.4 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.0 | 12.4 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
1.0 | 26.6 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.0 | 3.0 | GO:0038190 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) |
1.0 | 2.9 | GO:0051695 | actin filament uncapping(GO:0051695) phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.9 | 24.8 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.9 | 6.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.9 | 11.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.9 | 2.6 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.9 | 2.6 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.9 | 2.6 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.9 | 1.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.8 | 9.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.8 | 3.4 | GO:0021918 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
0.8 | 5.9 | GO:0048861 | oncostatin-M-mediated signaling pathway(GO:0038165) leukemia inhibitory factor signaling pathway(GO:0048861) |
0.8 | 2.5 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.8 | 3.3 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.8 | 3.3 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.8 | 2.4 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.8 | 7.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.8 | 4.0 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.8 | 4.8 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.8 | 1.6 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.8 | 2.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.8 | 3.2 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.8 | 2.4 | GO:0032827 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.8 | 40.1 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.8 | 2.3 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.7 | 36.0 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.7 | 4.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.7 | 2.2 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.7 | 3.7 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.7 | 5.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.7 | 2.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.7 | 2.1 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.7 | 2.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.7 | 2.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.7 | 2.1 | GO:0033189 | response to vitamin A(GO:0033189) |
0.7 | 3.5 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.7 | 6.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.7 | 6.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.7 | 4.7 | GO:1902861 | cellular response to cisplatin(GO:0072719) copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
0.7 | 8.8 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.7 | 5.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.7 | 6.6 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.7 | 11.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.6 | 3.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.6 | 3.8 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.6 | 2.5 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.6 | 5.6 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.6 | 4.3 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.6 | 2.9 | GO:0009750 | response to fructose(GO:0009750) |
0.6 | 2.3 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.6 | 0.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.6 | 8.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.6 | 1.7 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.6 | 6.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.6 | 29.0 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.6 | 22.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.5 | 3.2 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.5 | 6.5 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.5 | 4.2 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.5 | 6.8 | GO:0015747 | urate transport(GO:0015747) |
0.5 | 2.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.5 | 3.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.5 | 2.6 | GO:1902163 | negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
0.5 | 4.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.5 | 1.5 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.5 | 2.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.5 | 18.0 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.5 | 1.5 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.5 | 2.9 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.5 | 1.9 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.5 | 2.8 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.5 | 1.9 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.5 | 8.8 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.5 | 7.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.5 | 1.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.5 | 4.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 1.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 2.6 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.4 | 6.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.4 | 2.6 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.4 | 1.7 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.4 | 4.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.4 | 2.9 | GO:0019659 | glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.4 | 3.7 | GO:0019695 | choline metabolic process(GO:0019695) |
0.4 | 0.4 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.4 | 1.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.4 | 1.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.4 | 3.9 | GO:0070633 | transepithelial transport(GO:0070633) |
0.4 | 1.5 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.4 | 3.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.4 | 6.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.4 | 3.7 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.4 | 4.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 0.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.4 | 1.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 14.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.3 | 1.0 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.3 | 1.7 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.3 | 2.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.3 | 5.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 15.9 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 0.9 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 1.2 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.3 | 2.1 | GO:0042637 | catagen(GO:0042637) |
0.3 | 1.5 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.3 | 2.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 1.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.3 | 2.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 6.0 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.3 | 2.3 | GO:0031179 | peptide modification(GO:0031179) leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.3 | 9.5 | GO:0097286 | iron ion import(GO:0097286) |
0.3 | 5.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.3 | 2.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.3 | 0.8 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 6.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 2.7 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 0.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 1.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.3 | 1.3 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.3 | 3.9 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.3 | 2.0 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 | 2.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 1.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 1.5 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 3.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 2.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 2.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 0.2 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.2 | 4.5 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 1.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 1.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 2.6 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.6 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.2 | 0.6 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 3.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 0.4 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
0.2 | 1.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 1.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 1.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 3.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 1.8 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 3.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 6.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 0.6 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.2 | 15.8 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.2 | 1.9 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 1.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.6 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.2 | 2.2 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 10.5 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 1.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 2.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 0.7 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 1.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 1.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 7.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 5.0 | GO:0050892 | intestinal absorption(GO:0050892) |
0.2 | 9.2 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 5.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.2 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 1.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 2.6 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.2 | 4.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 1.4 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.2 | 4.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 1.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 1.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 7.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 1.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 4.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 1.9 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.1 | 1.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 22.3 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.1 | 1.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 5.1 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 0.5 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.1 | 0.5 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 2.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 1.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 3.7 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 2.9 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.6 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.1 | 8.7 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 2.3 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 1.9 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.1 | 2.5 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 2.6 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 18.3 | GO:0007596 | blood coagulation(GO:0007596) |
0.1 | 0.4 | GO:0015904 | tetracycline transport(GO:0015904) |
0.1 | 3.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 2.8 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 6.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 1.2 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.9 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.4 | GO:0099624 | atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 1.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.6 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 1.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 1.0 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.1 | 0.4 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.1 | 2.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 1.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 2.0 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 1.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.3 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.1 | 2.6 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.3 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.1 | 1.4 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 1.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 2.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 4.7 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.6 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 1.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 4.9 | GO:0001707 | mesoderm formation(GO:0001707) |
0.1 | 1.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.9 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 2.6 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.8 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.9 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 4.0 | GO:0051591 | response to cAMP(GO:0051591) |
0.1 | 0.6 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 1.6 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 1.7 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.7 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.1 | 1.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 1.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 1.2 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 44.5 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.1 | 2.0 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 1.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 6.5 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.1 | 0.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.2 | GO:0071110 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
0.1 | 13.6 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.1 | 0.3 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.2 | GO:0015786 | UDP-glucose transport(GO:0015786) |
0.1 | 1.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.9 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 0.8 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.4 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.0 | 0.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 2.1 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 4.2 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.9 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.7 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.6 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.2 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.0 | 0.7 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.6 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 3.6 | GO:0006865 | amino acid transport(GO:0006865) |
0.0 | 0.8 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 4.0 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.0 | 0.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.5 | GO:1904259 | positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 1.4 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 1.1 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.5 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.7 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 2.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.8 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.0 | 1.8 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.3 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.2 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.7 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.5 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.7 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.6 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 4.4 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.2 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 11.2 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.4 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.4 | 114.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
7.9 | 31.6 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
4.0 | 36.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
3.8 | 11.4 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
3.7 | 14.9 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
3.5 | 35.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
2.9 | 32.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
2.8 | 14.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
2.6 | 7.8 | GO:1902636 | kinociliary basal body(GO:1902636) |
2.5 | 22.9 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
2.3 | 46.2 | GO:0061702 | inflammasome complex(GO:0061702) |
2.2 | 6.6 | GO:0036020 | endolysosome membrane(GO:0036020) |
2.0 | 65.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.9 | 7.8 | GO:0097636 | platelet dense granule membrane(GO:0031088) intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
1.8 | 5.4 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
1.7 | 28.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
1.6 | 17.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.5 | 44.2 | GO:0031528 | microvillus membrane(GO:0031528) |
1.5 | 7.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.4 | 4.2 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
1.4 | 7.0 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
1.3 | 23.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.1 | 6.6 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
1.1 | 17.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
1.1 | 17.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.0 | 3.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.9 | 2.7 | GO:0014801 | longitudinal sarcoplasmic reticulum(GO:0014801) |
0.9 | 8.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.9 | 3.4 | GO:0005745 | m-AAA complex(GO:0005745) |
0.8 | 8.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.8 | 40.6 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.6 | 3.9 | GO:0097452 | GAIT complex(GO:0097452) |
0.6 | 1.9 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.6 | 2.4 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.6 | 2.9 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.6 | 16.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.5 | 5.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.5 | 3.7 | GO:0097444 | spine apparatus(GO:0097444) |
0.5 | 2.0 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.5 | 2.0 | GO:1990037 | Lewy body core(GO:1990037) |
0.5 | 38.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.5 | 2.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.5 | 2.0 | GO:0005757 | mitochondrial permeability transition pore complex(GO:0005757) |
0.5 | 28.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.5 | 8.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.5 | 3.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.5 | 5.0 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 6.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 43.1 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 28.0 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.4 | 2.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 44.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.4 | 101.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 1.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.4 | 3.0 | GO:0031673 | H zone(GO:0031673) |
0.3 | 1.0 | GO:0070069 | cytochrome complex(GO:0070069) |
0.3 | 1.4 | GO:0005879 | axonemal microtubule(GO:0005879) symmetric synapse(GO:0032280) |
0.3 | 3.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 1.3 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.3 | 1.2 | GO:0070722 | Tle3-Aes complex(GO:0070722) |
0.3 | 2.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 2.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 7.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 3.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 100.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 48.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 2.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 1.2 | GO:0071144 | activin responsive factor complex(GO:0032444) SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 1.1 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 72.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 2.7 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 3.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 5.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 1.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 1.0 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 5.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.6 | GO:0043291 | RAVE complex(GO:0043291) |
0.2 | 3.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 2.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 47.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 6.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 1.7 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 2.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 1.1 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 0.6 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 1.3 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 18.6 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 2.2 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 2.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 3.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 2.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 1.3 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 2.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 1.3 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.2 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.1 | 1.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 17.3 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 1.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 3.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 2.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 1.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 2.3 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 19.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 2.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 10.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 1.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 2.3 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.3 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.1 | 78.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) Golgi trans cisterna(GO:0000138) |
0.0 | 2.7 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 2.4 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.2 | GO:0098890 | extrinsic component of postsynaptic membrane(GO:0098890) |
0.0 | 1.7 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 2.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 1.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 1.4 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 4.4 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 4.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 3.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 6.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 3.9 | GO:0031674 | I band(GO:0031674) |
0.0 | 8.6 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 9.0 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 1.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 22.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 1.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 26.6 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 38.5 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
28.7 | 114.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
10.5 | 31.6 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
9.8 | 39.0 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
8.4 | 25.2 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
7.7 | 54.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
7.6 | 22.8 | GO:0003868 | 4-hydroxyphenylpyruvate dioxygenase activity(GO:0003868) quercetin 2,3-dioxygenase activity(GO:0008127) |
6.3 | 18.8 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
6.2 | 31.2 | GO:0035478 | chylomicron binding(GO:0035478) |
5.9 | 17.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
5.7 | 17.2 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
5.7 | 34.3 | GO:0004359 | glutaminase activity(GO:0004359) |
5.1 | 30.3 | GO:0015232 | heme transporter activity(GO:0015232) |
4.9 | 29.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
4.9 | 19.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
4.9 | 19.5 | GO:0004058 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
4.8 | 14.4 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
4.7 | 46.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
4.4 | 26.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
4.3 | 12.9 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
4.2 | 21.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
4.0 | 12.1 | GO:0005009 | insulin-activated receptor activity(GO:0005009) |
3.9 | 15.5 | GO:0043532 | angiostatin binding(GO:0043532) |
3.6 | 40.1 | GO:0035473 | lipase binding(GO:0035473) |
3.6 | 25.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
3.3 | 9.9 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
3.3 | 13.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
3.1 | 12.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
3.1 | 15.3 | GO:0070287 | ferritin receptor activity(GO:0070287) |
3.0 | 9.0 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
2.9 | 8.6 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
2.4 | 9.5 | GO:0047016 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity(GO:0047016) |
2.4 | 7.1 | GO:0045030 | UTP-activated nucleotide receptor activity(GO:0045030) |
2.3 | 7.0 | GO:0034012 | glycerone kinase activity(GO:0004371) FAD-AMP lyase (cyclizing) activity(GO:0034012) triokinase activity(GO:0050354) |
2.1 | 16.9 | GO:0005124 | scavenger receptor binding(GO:0005124) |
2.0 | 8.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
2.0 | 15.9 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.9 | 7.7 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
1.9 | 5.8 | GO:0016509 | long-chain-enoyl-CoA hydratase activity(GO:0016508) long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.9 | 3.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
1.8 | 5.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
1.6 | 4.7 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
1.5 | 7.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.5 | 24.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.4 | 14.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
1.4 | 9.9 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
1.4 | 5.4 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
1.4 | 4.1 | GO:0017099 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
1.3 | 10.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.3 | 38.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.3 | 3.8 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.2 | 23.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
1.2 | 4.9 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.2 | 6.0 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
1.2 | 5.9 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
1.2 | 8.2 | GO:0001851 | complement component C3b binding(GO:0001851) |
1.2 | 3.5 | GO:0070279 | vitamin B6 binding(GO:0070279) |
1.2 | 12.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.1 | 3.4 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
1.1 | 8.0 | GO:0016841 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) ammonia-lyase activity(GO:0016841) |
1.1 | 3.2 | GO:0047291 | lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
1.1 | 3.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
1.0 | 9.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.0 | 4.0 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
1.0 | 3.0 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
1.0 | 23.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.0 | 3.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
1.0 | 3.9 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.9 | 8.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.9 | 2.7 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.9 | 8.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.9 | 17.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.9 | 4.3 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
0.8 | 2.5 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.8 | 3.3 | GO:0036470 | tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
0.8 | 9.8 | GO:0015266 | protein channel activity(GO:0015266) |
0.8 | 2.4 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) |
0.7 | 4.5 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.7 | 8.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.7 | 8.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.7 | 4.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.7 | 10.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.7 | 6.7 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.7 | 27.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.7 | 2.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.7 | 9.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.6 | 2.6 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.6 | 5.7 | GO:0031433 | telethonin binding(GO:0031433) |
0.6 | 6.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.6 | 11.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.6 | 10.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 3.0 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.6 | 2.9 | GO:0051373 | FATZ binding(GO:0051373) |
0.6 | 17.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.5 | 2.2 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
0.5 | 45.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.5 | 3.8 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.5 | 3.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.5 | 2.6 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.5 | 2.0 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.5 | 3.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.5 | 8.9 | GO:0019841 | retinol binding(GO:0019841) |
0.5 | 1.5 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.5 | 5.8 | GO:0071949 | FAD binding(GO:0071949) |
0.5 | 2.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.5 | 2.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.5 | 11.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 4.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.4 | 5.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 17.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 2.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 2.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 14.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.4 | 2.1 | GO:0030984 | cysteine-type carboxypeptidase activity(GO:0016807) kininogen binding(GO:0030984) cysteine-type exopeptidase activity(GO:0070004) |
0.4 | 2.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 4.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 2.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.4 | 4.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 2.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.4 | 1.2 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.4 | 12.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 10.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.4 | 0.8 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.4 | 3.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 62.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 1.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 5.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.4 | 12.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.4 | 9.9 | GO:0009055 | electron carrier activity(GO:0009055) |
0.3 | 9.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.3 | 3.1 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 8.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 2.0 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 2.6 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.3 | 1.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 12.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 3.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 1.2 | GO:0050145 | cytidylate kinase activity(GO:0004127) uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 8.7 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.3 | 1.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.3 | 3.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 5.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 4.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 2.9 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 0.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 1.1 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.3 | 2.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 2.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 1.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.3 | 1.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 3.3 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.2 | 2.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 3.0 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 12.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 4.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 10.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 11.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 1.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 1.4 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.2 | 0.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 3.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 48.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 1.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 5.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 2.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 11.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 2.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 1.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 2.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 19.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 2.3 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.2 | 4.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 7.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 5.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 2.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 0.9 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 5.4 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.2 | 14.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 1.1 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 23.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 0.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 3.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 1.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 1.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 6.0 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 1.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 4.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 15.0 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 1.4 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 15.0 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 1.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 1.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 12.5 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.1 | 1.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 1.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 6.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 2.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 5.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.5 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.1 | 0.4 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.1 | 0.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 2.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 1.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 6.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 11.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 5.5 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 1.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 10.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.3 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.1 | 1.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 1.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 1.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 3.7 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.7 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.9 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 2.1 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 2.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 1.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 8.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.2 | GO:0004079 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.1 | 1.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 1.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 1.7 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 0.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 2.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 1.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.2 | GO:0031370 | eukaryotic initiation factor 4G binding(GO:0031370) |
0.0 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 3.4 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 2.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 2.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 15.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 1.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 2.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 7.8 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 1.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 0.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) RNA polymerase II activity(GO:0001055) |
0.0 | 1.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.7 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 1.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 1.0 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 1.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 4.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 2.7 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 23.7 | GO:0042803 | protein homodimerization activity(GO:0042803) |
0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.9 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 16.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 4.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.5 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.0 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 64.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.6 | 14.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 17.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 34.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 88.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 21.3 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 4.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 12.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 10.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 2.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 8.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 11.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 8.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 3.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 3.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 5.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 7.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 8.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 3.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 2.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 3.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 17.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 2.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 9.7 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 3.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 3.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 181.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
2.3 | 38.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
2.3 | 29.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.0 | 16.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
2.0 | 154.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
2.0 | 46.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.9 | 38.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.8 | 52.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.8 | 39.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.6 | 34.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.6 | 25.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.4 | 12.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.4 | 19.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.3 | 25.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.3 | 27.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.3 | 22.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.2 | 80.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.1 | 12.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.0 | 4.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.9 | 8.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.7 | 11.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.7 | 17.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.6 | 46.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.5 | 3.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 9.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 10.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 12.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.4 | 51.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 6.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.4 | 5.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 5.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 5.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 22.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.3 | 3.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 11.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 40.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 14.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 13.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 6.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 8.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 10.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 23.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 8.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 7.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 3.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 12.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 10.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 4.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 4.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 2.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 2.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 3.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 6.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 12.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 4.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 4.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 2.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 7.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 2.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 8.8 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 1.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 1.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 1.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.8 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 1.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 1.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 1.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 5.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 3.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.8 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 1.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.4 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |